Salicylic acid

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris, specifically for the management of pimples. It is administered by applying a patch directly to the affected area.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage form is a patch, which is to be administered topically. Healthcare professionals should ensure that the patch is applied to clean, dry, and intact skin. The application site should be free from any lotions, oils, or other topical products that may interfere with adhesion.

The patch should be applied once daily, and it is important to rotate the application site to minimize skin irritation. The patch should be worn continuously for 24 hours, after which it should be removed and replaced with a new patch at a different site.

In cases where the patch is not adhered properly or falls off, it should be replaced with a new patch, and the original dosing schedule should be maintained. It is essential to follow the prescribed dosing regimen and not to exceed the recommended frequency of application.

Contraindications

Use is contraindicated in patients with damaged or broken skin due to the potential for exacerbating the condition and causing further irritation.

Warnings and Precautions

To avoid the risk of suffocation, it is imperative to keep this plastic bag away from infants and children. This bag should not be used in cribs, beds, carriages, or playpens, as it poses a significant hazard. It is essential to recognize that this bag is not a toy.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should discontinue use and consult a healthcare professional if any rash or irritation develops. Prompt communication with a doctor is crucial to ensure appropriate management of any adverse reactions.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product.

Serious warnings include the risk of suffocation due to the plastic bag. It is imperative to keep this bag away from babies and children, and it should not be used in cribs, beds, carriages, or playpens, as it poses a significant danger. This bag is not intended to be a toy.

In the event that a rash and/or irritation occurs, patients are advised to stop using the product immediately and consult a doctor for further evaluation and guidance.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Tag Remover Patches. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product due to safety concerns. The plastic bag poses a suffocation risk; therefore, it must be kept away from infants and children. It is imperative that this bag is not used in cribs, beds, carriages, or playpens, as it is not a toy.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised. Caregivers should ensure that the product is stored out of reach of children to prevent any potential hazards.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of SKIN TAG REMOVER PATCHES during pregnancy. As such, the safety of this product in pregnant patients has not been established. There are no known safety concerns, dosage modifications, or special precautions indicated for use in this population. Healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There is no specific information regarding the use of Skin Tag Remover Patches in lactating mothers or any lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers about the use of this product. The potential effects on breastfed infants are not documented, and further research may be necessary to establish safety and efficacy in this population.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions recommended for individuals with compromised liver function. It is advised that healthcare professionals exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Healthcare professionals are advised to monitor the patient closely for any symptoms that may arise and to initiate appropriate management procedures as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to understand the potential risks associated with ingestion and the need for prompt action.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any rash or irritation while using the product. This precaution is essential to prevent further complications and ensure patient safety.

Additionally, healthcare providers should emphasize the importance of keeping the product out of the eyes. In the event of contact with the eyes, patients should be advised to rinse thoroughly with water to remove the product and minimize any potential irritation.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children. Once opened, the product must be discarded to ensure proper safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Skin Tag Remover Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)